Renee A Butler is an MBA, content writer, and marketing consultant with more than 13 years of experience. She specializes in life science, pharmaceutical research, finance, accounting, and technology.
6 Study Adaptations to Keep Studies Moving Despite COVID-19 Pandemic
The COVID-19 Pandemic continues to evolve and fluctuate across the globe – but not evenly or predictably. Some countries have recovered to a large or small degree of normalcy, while others are still in the midst of their battle with COVID-19 and seeing increasing infection rates. Simultaneously, most are preparing for a 2nd wave of COVID-19 to hit.
What we have found over the past few months of the COVID-19 pandemic is that you must adapt your study for the unique challenges of your individua...
Rare Disease Research in Central and Eastern Europe
There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world. However, individually, a rare disease can be defined as impacting fewer than 5 in 10,000. When indications are that sparse, developing treatments for rare diseases is challenging. Choosing the right location can make a difference. While the right site location will vary depending on the indication, some parts of the world are particularly well-suited to rare disease res...
Welcome to Pharm-Olam Insights
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Healthcare-associated infections (HAIs), also referred to as “nosocomial” or “hospital” infections, are infections that occur in...
“Adaptive designs” in clinical research refer to study designs where certain features are left flexible on purpose, so they can...
Join other Clinical Development experts to receive the latest in...
What is the Difference Between Microbiome and Microbiota?
Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It happens almost by a zeitgeist, with several locations around the world happening upon similar discoveries and subsequent researchers leveraging those findings to prompt an evolution of those understandings. The transformation manifests by a sudden influx of publications describing the phenomenon, but this change is evident in the volume of work surrounding the discovery. I...
The COVID 19 Map per ClinicalTrial Gov
The COVID Pandemic is continuing to evolve. Governments and companies around the world are striving to develop vaccines and treatments to limit the spread of the dangerous SARS-CoV2 virus (which causes COVID-19). These entities are conducting clinical trials to test the efficacy and safety of those options. Major movements are happening in COVID-19 research today.
In this article, we will explore the COVID 19 clinical trials landscape on ClinicalTrials.gov.
Trials in Progress
According to Cli...
Clinical Trials Today: Recent Milestones in Rare Cancer Research
Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened in 1903. Less than 100 years later, cancer preventatives were receiving approval. However, rare disease is more involved. In our last article, we looked at rare cancer research in detail. In this article, we will discuss rare oncology research today and moving forward.
Rare Cancer Research in Practice
The year 2020 saw many changes and breaking news stories, but one...
When Will Patients Return? The COVID Impact
Managing the COVID-19 pandemic has prompted countries and regions around the world to introduce a series of adaptions. For the most part, business as usual is underway, but some areas of life are still heavily impacted. One of the most significant issues for clinical research is patient recruitment and subject participation.
The Slow Road Out of Lockdown
Since March 2020, over 500 companies have announced that clinical trials were disrupted because of COVID-19 restrictions. While most of thes...
Infectious Disease Research: Importance of Site Location in Clinical Trials
Site location plays an important role in clinical trials. The impact of location comes into play for most therapeutic areas. In the same way that allergy studies need to be planned with respect to the allergens studied, infectious disease clinical trials have to take place where those diseases are prevalent.
Natural Selection Amongst Pathogens
Pathogens tend to thrive in specific ecosystems, and ancient history reflects that connection. Researchers Karlsson, Kwiatkowski, and Sabeti (2014) exp...
Pharm-Olam Enrolling UK Volunteers for Phase 3 Valneva COVID-19 Vaccine Study
HOUSTON, Texas, May 10, 2021 – Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases, vaccines, rare and orphan diseases along with oncology, is now enrolling volunteers in the United Kingdom into a pivotal Phase III COVID-19 vaccine study. Visit ukcovid19study.com for more information about participation.
The Phase III “Cov-Compare” trial (VLA2001-301) will compare Valneva’s SARS-CoV-2 vaccine candidate, VLA2001, against AstraZeneca’s...
The Use of Protein Replacement Therapies in Rare Disease Research
Rare disease research can take many forms, and each drug development platform offers specific advantages researchers can leverage to address elements of these conditions. Earlier, we began to discuss research within the field of rare disease (read the article here). We reviewed an article from Nature (you can access it here) and went in detail about specific types of rare disease research in subsequent articles. At this point, we have covered small molecules (click here) and antibody therapy ...
New Customer Acquisition Strategies for Ecommerce
The growth of online sales as a percentage of all retail continues to grow, but ecommerce itself is beginning to mature — and that online retailers were having to change their business models to reflect that. Whereas a novel concept or a low price was once enough to get customers to visit the site, the maturity of the channel meant that companies needed to shift their focus towards more sophisticated analysis that examines more fragmented ways visitors find their site and the rate at which th...
Going Long for Kraft Heinz: A Dividend Play and Growth
Finding a company for a good long position and a little regular income is not an easy feat. The larger dividend yields tend to be offered by mature companies with little debt that may not need to reinvest all of their earnings. Retaining that cash would have resulted in a cash surplus and shifted the companies’ capital structures. It also helps attract investors when year over year growth is not very high.
Declining Construction Spending Could Spell Trouble for Home Improvement Giants
Month over month construction spending is contracting, particularly in private construction and home improvement, and that could spell trouble for companies in the home improvement industry.
Spending on home improvement projects fell almost 2% in May while private construction spending was down 1.5%. "The recent flattening out in housing activity could prove more protracted than currently expected rather than resuming its earlier pace of recovery," said Federal Reserve Chair Janet Yellen in May. She continued by warning that housing activity has been disappointing this year...
US Retail Sales Point to a Bleak Future for One Retailer
Chain store sales are popping. Week over week the change is only 1%, according to ICSC-Goldman, but year over year chain store sales are strong. Retail sales have increased 4.6%, their largest boost since December 2011. This is a good sign for the economy at large. Consumer spending is responsible for over two-thirds of the economy and this tends to translate into higher profits for retail companies and, in turn, higher stock prices. But not every company is likely to see gains.
Understanding Your Company's Financial Reports
Business owners tend to develop strong relationships with their accountants. usually at least once a quarter you sit down to figure out where your company stands and how much it owes in taxes. You might also meet a couple times a year to plan when you will make certain investments in your business or how you will structure wages so that you get the greatest tax benefit.